Literature DB >> 11914954

Cytotoxic activity of sesquiterpenoids from Atractylodes ovata on leukemia cell lines.

Ching-Chiung Wang1, Lih-Geeng Chen, Ling-Ling Yang.   

Abstract

The rhizome of Atractylodes ovata (Bai Zhu in Chinese) is a widely used traditional Chinese herb in Taiwan as a tonic agent. In this paper, four sesquiterpenoids, namely atractylon, and atractylenolides I, II, and III, were isolated from the n-hexane extract of A. ovata and were evaluated for cytotoxic effects in vitro. Atractylon significantly inhibited the growth of human leukemia cell line HL-60 and mouse leukemia cell line P-388, and showed low cytotoxicity against primary cultures of normal human peripheral blood mononuclear cells at 15 microg/ml for 12 h. Atractylon had a dose-dependent antiproliferative effect on the two tumor cell lines. In accordance with DNA fragment increases and PARP protein decreases, atractylon at 15 microg/ml for 6 h induced apoptosis in HL-60 cells. Moreover, atractylon inhibited the viability of P-388 cells and induced apoptosis after 15 microg/ml treatment for 12 h in an in vitro assay. However, atractylenolide I at 30 microg/ml for 12 h also induced apoptosis in HL-60 and P-388 cells, but atractylenolides II and III showed no significant inhibition effects on tumor cell growth. As the above results suggested, atractylon and atractylenolide I were the major cytotoxic principle constituents of A. ovata on leukemia cell lines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11914954     DOI: 10.1055/s-2002-23144

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  12 in total

1.  Induction of apoptosis in human lymphoblastoid cells by kaempferol 3-O-β-isorhamninoside and rhamnocitrin 3-O-β-isorhamninoside from Rhamnus alaternus L. (Rhamnaceae).

Authors:  W Bhouri; I Bouhlel; J Boubaker; S Kilani; K Ghedira; L Chekir Ghedira
Journal:  Cell Prolif       Date:  2011-06       Impact factor: 6.831

2.  Volatile secondary metabolites as aposematic olfactory signals and defensive weapons in aquatic environments.

Authors:  Giuseppe Giordano; Marianna Carbone; Maria Letizia Ciavatta; Eleonora Silvano; Margherita Gavagnin; Mary J Garson; Karen L Cheney; I Wayan Mudianta; Giovanni Fulvio Russo; Guido Villani; Laura Magliozzi; Gianluca Polese; Christian Zidorn; Adele Cutignano; Angelo Fontana; Michael T Ghiselin; Ernesto Mollo
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-13       Impact factor: 11.205

3.  Quantitative determination of atractylon in Atractylodis Rhizoma and Atractylodis Lanceae Rhizoma by 1H-NMR spectroscopy.

Authors:  Keiko Hasada; Takamitsu Yoshida; Takeshi Yamazaki; Naoki Sugimoto; Tetsuji Nishimura; Akito Nagatsu; Hajime Mizukami
Journal:  J Nat Med       Date:  2010-02-19       Impact factor: 2.343

4.  Selective fraction of Atractylodes lancea (Thunb.) DC. and its growth inhibitory effect on human gastric cancer cells.

Authors:  Ming Zhao; Qingqing Wang; Zhen Ouyang; Bangxing Han; Wenbing Wang; Yuan Wei; Yan Wu; Bing Yang
Journal:  Cytotechnology       Date:  2013-04-07       Impact factor: 2.058

5.  Investigation of the apoptotic way induced by digallic acid in human lymphoblastoid TK6 cells.

Authors:  Wissem Bhouri; Jihed Boubaker; Ines Skandrani; Kamel Ghedira; Leila Chekir Ghedira
Journal:  Cancer Cell Int       Date:  2012-06-11       Impact factor: 5.722

6.  Inhibition of inducible nitric oxide synthase and osteoclastic differentiation by Atractylodis Rhizoma Alba extract.

Authors:  Sung-Ho Choi; Sung-Jin Kim
Journal:  Pharmacogn Mag       Date:  2014-08       Impact factor: 1.085

Review 7.  Atractylenolides (I, II, and III): a review of their pharmacology and pharmacokinetics.

Authors:  Mao Deng; Huijuan Chen; Jiaying Long; Jiawen Song; Long Xie; Xiaofang Li
Journal:  Arch Pharm Res       Date:  2021-07-16       Impact factor: 4.946

Review 8.  Traditional Chinese Medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis.

Authors:  Ping Wu; Jean Jacques Dugoua; Oghenowede Eyawo; Edward J Mills
Journal:  J Exp Clin Cancer Res       Date:  2009-08-12

9.  A randomized pilot study of atractylenolide I on gastric cancer cachexia patients.

Authors:  Yi Liu; Zhongwu Jia; Lei Dong; Rui Wang; Genquan Qiu
Journal:  Evid Based Complement Alternat Med       Date:  2008-09       Impact factor: 2.629

10.  Anti-tumor effects of Atractylenolide I on bladder cancer cells.

Authors:  Rui Yu; Bi-Xia Yu; Jun-Feng Chen; Xiu-Yi Lv; Ze-Jun Yan; Yue Cheng; Qi Ma
Journal:  J Exp Clin Cancer Res       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.